October 19, 2023

Antiva Biosciences Strengthens Leadership with Key New Appointments Read more

May 5, 2023

ANNOUNCEMENT: ASCCP Presents Dr. Tom Cox with Lifetime Achievement Award Read more

April 27, 2023

Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO Read more

January 6, 2022

Antiva Biosciences Named Winner of Global Women’s HealthTech Award by World Bank Group and Consumer Technology Association Read more

November 2, 2021

Antiva Biosciences Closes $31 Million Series D Equity Financing Read more

April 21, 2021

Antiva Biosciences Appoints Clifford Samuel to Board of Directors Read more

November 9, 2018

Antiva’s Gail Maderis Finds Inspiration in Today’s Biotech Innovation Read article (BioSpace)

November 8, 2018

San Francisco Business Times Names Gail Maderis One of 2018’s Most Admired CEOs Read article (SF Business Times)

August 16, 2018

A Women’s Health Startup Tried to Drum Up Interest for a Much-Needed Drug. Many Men Didn’t Get It Read article (STAT)

July 10, 2018

Antiva Biosciences Closes $15 Million Series C-1 Financing Read more

March 28, 2017

Antiva Biosciences Closes $22 Million Series C Financing Read more

August 6, 2015

Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections Read more

August 6, 2015

With $16M Series B, Antiva Hopes to Kill Cancer-Causing HPV Read article (Xconomy)

August 6, 2015

Why a longtime biotech exec shunned retirement for a 'breakthrough' Read article (SF Business Journal)